Applied Lipid Technologies

Innovative lipid-based therapeutics for inherited blood disorders

ABOUT APPLIED LIPID

Addressing Sickle Cell Disease Through Lipid Science

Applied Lipid Technologies (ALT) is creating safe and cost-effective solutions to diseases involving cell membranes. Our focus is on developing innovative therapies for sickle cell disease, an inherited blood disorder affecting millions worldwide.

Sickle cell disease causes red blood cells to become misshapen, leading to blockages in blood vessels, chronic pain, organ damage, and reduced life expectancy. Current treatments have significant limitations.

OUR PROGRAMS

Development Pipeline

Phase 2a

S-100

Lipid-Based Therapeutic for Sickle Cell Disease

S-100 is a unique lipid-based therapeutic candidate designed to address the underlying cellular membrane dysfunction in sickle cell disease. The compound aims to improve red blood cell flexibility and reduce sickling events.

MARKET READY

Altemia®

Medical Food for Sickle Cell Disease Nutritional Support

Altemia® is a medical food brand providing nutritional support specifically designed for individuals managing sickle cell disease. The product is currently available and supports overall health in SCD patients.

View Our Complete Pipeline

See all development programs across Lobe Sciences and its subsidiaries.